Semler Scientific

Semler Scientific, Inc.

Semler Scientific, Inc. is a U.S. healthcare technology company that develops, manufactures, and markets products and services intended to support the early detection and management of chronic diseases, with an emphasis on vascular disease screening. (semlerscientific.com)

Core product and focus

The company’s flagship product is QuantaFlo®, a patented, FDA-cleared point-of-care test designed to measure arterial blood flow in the extremities and help clinicians identify peripheral arterial disease (PAD) in minutes, including in patients who may be asymptomatic. (semlerscientific.com)

Corporate and investor context

Semler Scientific is a publicly traded company (commonly associated with the ticker SMLR) and operates a healthcare business centered on QuantaFlo and related services. (ir.semlerscientific.com)
Its investor-relations materials also state that, beginning in May 2024, the company adopted bitcoin as its primary treasury reserve asset and has pursued a bitcoin treasury strategy alongside its healthcare operations. (ir.semlerscientific.com)

Headquarters and contact (as published by the company)

Semler Scientific lists an address in Campbell, California (USA) and provides a main phone number for inquiries. (semlerscientific.com)

Leadership (from the company website)

The company’s leadership page identifies Doug Murphy-Chutorian as Chief Executive Officer and Eric Semler as Executive Chairman. (semlerscientific.com)

Online presence

• Official website (as provided): https://www.semlerscientific.com/ (semlerscientific.com)
• X (Twitter) account (as provided): https://x.com/SemlerSci (note: X pages may require sign-in to view full details in some contexts).